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UNTANGLING CELLULAR AND MOLECULAR  
MECHANISMS OF FIBROTIC DISEASE
 1.  Gli1 expression marks perivascular mesenchymal stem cells (MSCs) across 
major organ systems (this thesis).
 2.  Gli1+ perivascular MSCs are a major source of fibrosis-driving myofibroblasts in 
kidney, heart and bone marrow and their genetic ablation ameliorates fibrosis 
and stabilizes organ function (this thesis).
 3.  Gli proteins are important drivers of myofibroblast cell-cycle progression and 
a promising therapeutic target to inhibit myofibroblast expansion and fibrosis 
(this thesis).
 4.  Resident pericytes are the major source of myofibroblasts while circulating 
monocytes show a minor contribution primarily, however, through indirect 
pro-inflammatory mechanisms (this thesis).
 5.  Fibrosis is a conserved mechanism across organ systems, which initially aids in 
tissue repair but during chronic injury becomes a disease by itself destroying 
organ architecture and leading to organ failure.
 6.  Switching resident pericytes from a pro-fibrotic towards a pro-angiogenic 
phenotype might be a novel therapeutic strategy to inhibit fibrosis and 
promote tissue repair.
 7.  The tremendous heterogeneity of the pericyte lineage is incompletely under-
stood and of tremendous importance for understanding tissue injury, fibrosis 
and repair processes. 
 8  Cross-talk of resident mesenchymal cells and circulating immune cells is a 
major driver of tissue fibrosis and scar formation.
 9.  To untangle mechanisms of complex diseases and to develop novel therapeutics 
large collaborative approaches of academia and industry are needed.  
 10.  The culture of “publish or perish” and the short lifespan of most research 
grants slow down progression of science.
 11.  Only those who attempt the absurd can achieve the impossible  
(Albert Einstein).
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